Clinical trial NCT05620979: Financial Navigation Study Among Young Adult Blood Cancer Survivors
Official title: Evaluating the Role of Financial Navigation in Alleviating Financial Distress Among Young Adult Survivors of Blood Cancer
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Survivorship
Cancer
Financial Stress
Lead sponsor: Tufts Medical Center
Sponsor class: OTHER
Collaborators: name: The Leukemia and Lymphoma Society
First posted: 2022-11-17
Enrollment: 130
Sex: ALL
Minimum age (years): 18
Maximum age (years): 39
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Intervention model description: This is a multi-site, three-arm, financial navigation intervention
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

Detailed description: This fully remote, multi-site study will evaluate the role of financial navigators in relieving financial distress in young adults (18-39y) who have completed treatment for blood cancer at least three years ago. Serial Assessments at study entry, 3-months, and 6-months measure financial distress measured using the study's primary outcome measure the Personal Financial Wellness Scale™ (PFW) (see below), hypothesized effect modifiers (emotional distress, self-efficacy, cognitive functioning), as well as care seeking, household finances and insurance characteristics. Randomization will occur following completion of baseline measures (see below for description of study arms). In addition to a formal evaluation of the intervention at 3- and 6-months, an optional interview will occur following the 6-month assessment/navigation intervention period to gain further insight from participants about the acceptability of the intervention. For ethical considerations related to the topic of study, all participants will be provided with the Leukemia \& Lymphoma Society's information specialist hotline.

Eligibility criteria: Inclusion Criteria:

1. Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm)
2. Current age between 18-39 years old
3. Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood (18-36 years of age)
4. At least three years post blood cancer diagnosis
5. Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer medication with stable disease
6. Off treatment for a second cancer (non-blood cancer) or on a stable long-term regimen, such as hormone therapy or hormone replacement therapy
7. Primary residence in United States
8. Able to understand and read the English language

Exclusion Criteria:

* On parent or guardian's insurance

Primary outcomes:
measure: Personal Financial Wellness Scale (PFW)
timeFrame: 6 months
Secondary outcomes:
measure: Health-Related Quality of Life (HrQoL) Measures
timeFrame: 6 months
Other outcomes:
Locations:
city: Los Angeles
country: United States
facility: Children's Hospital Los Angeles
state: California
city: Los Angeles
country: United States
facility: University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital)
state: California
city: Boston
country: United States
facility: Tufts Medical Center
state: Massachusetts
city: Greenville
country: United States
facility: Bon Secours Mercy Health System
state: South Carolina
city: Houston
country: United States
facility: MD Anderson
state: Texas
Study officials:
affiliation: Tufts Medical Center
name: Susan K Parsons, MD, MRP
role: PRINCIPAL_INVESTIGATOR
References: